Related Experiment Video
Updated: Jul 16, 2026

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
Published on: June 11, 2015
In vitro studies of platelet adhesion, activation, and protein adsorption on curcumin-eluting biodegradable stent
1School of Materials Science and Engineering, SouthWest Jiaotong University, Chengdu 610031, China.
Insights
Curcumin-eluting films loaded onto coronary stents show improved blood compatibility. These drug-eluting stents can prevent thrombus formation and reduce in-stent restenosis (ISR).
Area of Science:
- Biomaterials Science
- Cardiovascular Research
- Drug Delivery Systems
Background:
- In-stent restenosis (ISR) is a significant complication following coronary stenting, often caused by thrombus formation.
- Curcumin exhibits antithrombotic properties, suggesting its potential for preventing ISR when locally released.
Purpose of the Study:
- To fabricate and evaluate curcumin-eluting polylactic acid-co-glycolic acid (PLGA) films for enhanced blood compatibility.
- To assess the potential of these films in preventing thrombosis for coronary stent applications.
Main Methods:
- Fabrication of curcumin-eluting PLGA films.
- In vitro evaluation of blood compatibility, including platelet adhesion, activation, and protein adsorption.
- Structural analysis using Fourier transform infrared spectroscopy (FTIR) and X-ray photoelectron spectroscopy (XPS).
- Contact angle and surface free energy measurements.
Main Results:
- Curcumin incorporation into PLGA films did not alter curcumin's structure.
- Curcumin-eluting films exhibited increased hydrophilicity and a higher polar fraction of surface free energy.
- Significant reduction in platelet adhesion and activation on curcumin-loaded films.
- Marked decrease in fibrinogen adsorption with curcumin loading.
Conclusions:
- Incorporating curcumin into PLGA films significantly improves their blood compatibility.
- Curcumin-eluting PLGA films demonstrate potential for fabricating drug-eluting stents to prevent thrombosis and ISR.
Abstract:
A major complication of coronary stenting is in-stent restenosis (ISR) due to thrombus formation. We hypothesized that locally released curcumin from coronary stent surface would inhibit ISR due to thrombus formation because of antithrombosis of curcumin. In the present work, curcumin-eluting polylactic acid-co-glycolic acid (PLGA) films were fabricated and their properties in vitro were investigated. The in vitro platelet adhesion and activation, as well as protein adsorption on curcumin-loading PLGA films were investigated to evaluate the blood compatibility of curcumin-eluting films. The structure of curcumin-eluting PLGA film and control was examined by Fourier transform infrared spectroscopy and X-ray photoelectron spectroscopy indicating that the peaks of curcumin did not shift in curcumin-eluting films. The results of contact angle and surface free energy indicated that loading curcumin in PLGA would make PLGA become more hydrophilic, which contributed to the increase of polar fraction of surface free energy. With the increase of curcumin in films, platelets adhering to the curcumin-eluting films decreased significantly. The number of activation platelets decreased after incorporating curcumin in PLGA films. Loading curcumin in PLGA film can markedly reduce the fibrinogen adsorption. All results indicated that incorporating curcumin in PLGA film can improve the blood compatibility of PLGA films. It can be used to fabricate drug-eluting stent to prevent thrombosis formation.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Intracellular Signaling Affects Focal Adhesions
Some...

